An Interventional Study (Calcium Supplementation & Health Education) On Premenstrual Syndrome - Effect on Premenstrual and Menstrual Symptoms

The study was conducted to study the effect of calcium supplementation on Premenstrual and Menstrual Symptoms. It was a one-year follow-up prospective, randomized controlled interventional study. After the initial 2-cycle screening phase, a total of 215 healthy premenopausal women were enrolled in t...

Full description

Saved in:
Bibliographic Details
Main Authors: Shailesh Sutariya (Author), Nitiben Talsania (Author), Chintul Shah (Author), Mitesh Patel (Author)
Format: Book
Published: Medsci Publications, 2011-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8efa21d7aa9e44df91ed95e9ee0e1df9
042 |a dc 
100 1 0 |a Shailesh Sutariya  |e author 
700 1 0 |a Nitiben Talsania  |e author 
700 1 0 |a Chintul Shah  |e author 
700 1 0 |a Mitesh Patel  |e author 
245 0 0 |a An Interventional Study (Calcium Supplementation & Health Education) On Premenstrual Syndrome - Effect on Premenstrual and Menstrual Symptoms 
260 |b Medsci Publications,   |c 2011-06-01T00:00:00Z. 
500 |a 0976-3325 
500 |a 2229-6816 
520 |a The study was conducted to study the effect of calcium supplementation on Premenstrual and Menstrual Symptoms. It was a one-year follow-up prospective, randomized controlled interventional study. After the initial 2-cycle screening phase, a total of 215 healthy premenopausal women were enrolled in the study group calcium supplementation (500 BD) of the trial and 140 subjects either the relatives or neighbors of the study population were enrolled as control group health, nutrition, hygiene education of the trial. By the second and third treatment months, all symptoms except for fatigue and insomnia showed a significant response to calcium. For the symptom of low backache, the mean screening score was significantly higher than the control group score (0.82±0.74 vs 0.69±0.66, p=0.033) and became significantly lower than the control group score by the end of third treatment cycle. (0.30±0.45 vs 0.49±0.59, p<0.01). Nearly half (55%) of the women in the study group reported ≥50% improvement and one-third (30%) of the women in study group reported ≥75% improvement. Significantly lower symptoms score was detected in the urban sites during the first treatment phase with calcium and during the final treatment phase. 
546 |a EN 
690 |a Premenstrual Syndrome 
690 |a calcium supplement 
690 |a intervention 
690 |a health education 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n National Journal of Community Medicine, Vol 2, Iss 01 (2011) 
787 0 |n https://njcmindia.com/index.php/file/article/view/1853 
787 0 |n https://doaj.org/toc/0976-3325 
787 0 |n https://doaj.org/toc/2229-6816 
856 4 1 |u https://doaj.org/article/8efa21d7aa9e44df91ed95e9ee0e1df9  |z Connect to this object online.